America Latina Times: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on America Latina Times.

Press releases published on August 25, 2026

Aug. 25, 2026

SERB Applauds Publication of Consensus Statements and Recommendations for Neuroblastoma Care in Pediatric Blood & Cancer

Indeterminate GlobeNewswire

Aug. 25, 2026

Trident Resources Announces the Commencement of an Airborne Magnetic and Radiometric Geophysical Survey over the Reindeer Gold Property

Indeterminate GlobeNewswire

Aug. 25, 2026

Parabilis Medicines Appoints Accomplished Drug Development Leader Craig L. Tendler, M.D., to Board of Directors

Indeterminate GlobeNewswire

Aug. 25, 2026

NexGold Intersects 3.08 g/t over 17.0 Metres, 4.80 g/t Gold over 5.6 Metres, 84.30 g/t over 1.0 Metres and Expands Drilling Program at the Goldlund Deposit, Ontario

Indeterminate GlobeNewswire

Aug. 25, 2026

GoldInxs Strengthens Corporate Development and Investor Communications with Key Appointment and ICG Engagement

Indeterminate GlobeNewswire

Aug. 25, 2026

Lotus Tech Completed Acquisition of 100% Equity Interest of Lotus Advance Technologies, Integrating All Businesses and Operations Under One Lotus

Indeterminate GlobeNewswire

Aug. 25, 2026

GFG and Barrick Sign Strategic Earn-In to Accelerate Exploration at the Pen Gold Project

Indeterminate GlobeNewswire

Aug. 25, 2026

First Atlantic Nickel & Cobalt Attends the Defense Industrial Base Accelerator (DIBX) 2026, Showcasing Awaruite (Ni-Fe-Co Alloy) Samples Processed with ONSHORE MAX™ Into an Alloy Concentrate Up to 71.9% Nickel and 1.76% Cobalt from the Pipestone XL…

Indeterminate GlobeNewswire

Aug. 25, 2026

Astrocyte Pharmaceuticals Receives NIH Award to Evaluate AST-004 in Substance Use Disorders

Indeterminate GlobeNewswire

Aug. 25, 2026

Greenland Mines Sarfartoq Nd-Pr Rare Earth Project Valued Up to US$2.05 Billion With Pre-Tax IRR of 118.6% and Significant Additional Upside Potential

Indeterminate GlobeNewswire

Aug. 25, 2026

Leads Biolabs’ Opamtistomig (PD-L1/4-1BB Bispecific Antibody) Phase II Clinical Study for First-Line Treatment of Esophageal Squamous Cell Carcinoma Advances to Expansion Stage

Indeterminate GlobeNewswire

Aug. 25, 2026

Helium Evolution Closes $25 Million Private Placement

Indeterminate GlobeNewswire